Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has made significant investments in wealth management products, subscribing to structured deposits across Industrial Bank, CITIC Bank, and CZB, with a total outstanding principal of RMB 1.01 billion. These investments, aimed at enhancing financial returns, have been classified as discloseable transactions under Hong Kong’s Listing Rules due to their substantial size. Investors may find these strategic financial moves noteworthy as they reflect the company’s approach to asset management and risk diversification.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.